Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$20.47
$20.47
$16.79
$21.74
$24.71B1.42250,997 shsN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
$31.00
+1.2%
$31.00
$21.90
$33.57
$22.55B0.997,322 shs39,400 shs
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
$22.00
0.0%
$22.00
$10.00
$31.55
$21.91B0.681,758 shs7,500 shs
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
$24.38
-1.2%
$24.38
$18.50
$31.96
$6.64B1.811,665 shs200 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
0.00%0.00%0.00%+3.18%+1.44%
Ferrovial SE stock logo
FRRVY
Ferrovial
0.00%0.00%0.00%0.00%0.00%
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
0.00%0.00%0.00%0.00%0.00%
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
N/AN/AN/AN/AN/AN/AN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/AN/AN/AN/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
N/AN/AN/AN/AN/AN/AN/AN/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
2.67
Moderate BuyN/AN/A
Ferrovial SE stock logo
FRRVY
Ferrovial
0.00
N/AN/AN/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
0.00
N/AN/AN/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest SWTUY, EPOKY, FRRVY, and HLUYY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/29/2025
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
Pareto Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$6.02B4.11$0.95 per share21.54$3.38 per share6.06
Ferrovial SE stock logo
FRRVY
Ferrovial
$7.96B2.83$0.31 per share99.44$9.15 per share3.39
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
$2.59B8.45$3.36 per share6.54$14.60 per share1.51
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
$763.19M8.71$0.70 per share34.66$2.88 per share8.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$825.95M$0.6830.1023.263.9313.74%21.50%10.73%7/18/2025 (Estimated)
Ferrovial SE stock logo
FRRVY
Ferrovial
$187.57MN/A0.00N/AN/AN/AN/AN/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
$209.69M$0.8825.007.72N/A6.74%13.74%7.16%N/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
$134.73M$0.5048.7616.931.3025.75%29.63%18.74%N/A

Latest SWTUY, EPOKY, FRRVY, and HLUYY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/18/2025N/A
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$0.1683N/AN/AN/A$15.76 billionN/A
4/29/2025Q1 2025
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$0.17$0.17N/A$0.17$16.02 billion$1.46 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
$0.170.83%N/A25.00%N/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/AN/AN/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
$0.200.91%N/A22.73%N/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
0.45
2.48
1.43
Ferrovial SE stock logo
FRRVY
Ferrovial
N/AN/AN/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
0.32
1.15
0.71
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
N/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
N/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
N/A

Insider Ownership

CompanyInsider Ownership
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
N/A
Ferrovial SE stock logo
FRRVY
Ferrovial
N/A
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
N/A
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Epiroc AB (publ) stock logo
EPOKY
Epiroc AB (publ)
17,9231.21 billionN/ANot Optionable
Ferrovial SE stock logo
FRRVY
Ferrovial
18,680727.44 millionN/ANot Optionable
H. Lundbeck A/S stock logo
HLUYY
H. Lundbeck A/S
5,348995.74 millionN/ANot Optionable
SWEDISH ORPHAN/S stock logo
SWTUY
SWEDISH ORPHAN/S
902272.51 millionN/ANot Optionable

Recent News About These Companies

RBC Capital Remains a Buy on Swedish Orphan Biovitrum AB (0MTD)
High Growth Tech Stocks In Sweden With Promising Potential
Exploring Sweden's High Growth Tech Giants

New MarketBeat Followers Over Time

Media Sentiment Over Time

Epiroc AB (publ) stock logo

Epiroc AB (publ) OTCMKTS:EPOKY

$20.47 0.00 (0.00%)
As of 04/25/2025

Epiroc AB (publ), together with its subsidiaries, develops and produces equipment for use in surface and underground applications in North America, Europe, South America, Europe, Africa, the Middle East, Asia, and Australia. It operates in two segments, Equipment & Service, and Tools & Attachments. The Equipment & Service segment provides equipment and solutions for rock drilling, rock excavation, rock reinforcement, loading and haulage, and ventilation systems, as well as drilling equipment for exploration, and water and energy; and related spare parts and services for the mining and infrastructure industries. This segment offers solutions for automation, digitalization, and electrification. The Tools & Attachments segment provides consumables for rock drilling, such as drill bits and drill rods, as well as tools for exploration drilling and rock reinforcement; ground engaging tools, such as cast lips, teeth, and protective shrouds, as well as digital solutions for the mining industry; and hydraulic attachments, including hydraulic breakers, shears and pulverizers, concrete cutters and busters, drum cutters, excavator grapples, excavator magnets, hydraulic compactors, crusher and screening buckets, auger drive units, and couplers and thumbs, as well as HATCON that is a remote monitoring tool. In addition, the company offers aftermarket services, including new circular services, productivity-enhancing technology-agnostic digital solutions, mid-life upgrades, diesel-to-battery conversions, and remanufacturing of components. Epiroc AB (publ) was founded in 1873 and is headquartered in Nacka, Sweden.

Ferrovial stock logo

Ferrovial OTCMKTS:FRRVY

$31.00 +0.37 (+1.21%)
As of 08/3/2023

Ferrovial SE, together with its subsidiaries, develops transport infrastructure, mobility solutions, civil works, and buildings projects in Spain and internationally. The company designs and builds various public and private works; and develops, finances, and operates toll roads. Its construction activities include highways, tunnels, bridges, and airports; designs, constructs, operates and maintains potable water treatment plants, urban and industrial waste water treatment plants, and desalination plants. In addition, the company manufactures and markets asphalt and bitumen products; develops, operates, and manages airports; and promotes, constructs, and operates energy generation and transmission infrastructures. Further, it provides mobility services, include ZITY, an electric carsharing service application; invests in electric vehicle sector, including cars and associated charging infrastructures; and sells, rents, and maintains hydraulic equipment, jacks, and floating caisson equipment. The company was founded in 1952 and is based in Madrid, Spain.

H. Lundbeck A/S stock logo

H. Lundbeck A/S OTCMKTS:HLUYY

$22.00 -0.01 (-0.02%)
As of 08/9/2022

H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.

SWEDISH ORPHAN/S stock logo

SWEDISH ORPHAN/S OTCMKTS:SWTUY

$24.38 -0.29 (-1.18%)
As of 04/9/2019

Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.